Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma.
Schulte L, Scheiner B, Voigtländer T, Koch S, Schweitzer N, Marhenke S, Ivanyi P, Manns MP, Rodt T, Hinrichs JB, Weinmann A, Pinter M, Vogel A, Kirstein MM.
Schulte L, et al. Among authors: vogel a.
Liver Int. 2019 Apr;39(4):714-726. doi: 10.1111/liv.14048. Epub 2019 Feb 7.
Liver Int. 2019.
PMID: 30663219